Effect of Valsartan Compared to Enalapril on Sitting Systolic Blood Pressure in Children With High Blood Pressure
Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this 12-week active controlled trial is to evaluate the safety and efficacy of
valsartan 80/160/320 mg (weight stratified) compared with enalapril 10/20/40 mg (weight
stratified) on sitting systolic blood pressure (SSBP) in 6 - 17 year old children with
hypertension (SSBP ≥ 95th percentile for age gender and height).